ECLS-associated infections in adults: what we know and what we don't yet know
- PMID: 31768569
- PMCID: PMC7222121
- DOI: 10.1007/s00134-019-05847-z
ECLS-associated infections in adults: what we know and what we don't yet know
Abstract
Extracorporeal life support (ECLS) is increasingly used in the management of patients with severe cardiopulmonary disease. Infections are frequently the etiologies underlying the respiratory, and occasionally cardiac, failure that necessitates ECLS. Just as importantly, infections are among the most commonly reported adverse events during ECLS. Infections in this setting may be the sequelae of prolonged critical illness or of underlying immune dysregulation; they may be hospital-acquired infections, and they may or may not be attributable to the presence of ECLS itself, the latter being an aspect that can be difficult to determine. Current registry data and evidence from the literature offer some insights, but also leave open many questions regarding the nature and significance of infections reported both before and during ECLS, including the question of any causal link between ECLS and the development of infections. An ongoing lack of consistency in the identification, diagnosis, management, and prevention of infections during ECLS is limiting our ability to interpret literature data and thus highlighting the need for more rigorous investigation and standardization of definitions. This review aims to characterize the current understanding of infections associated with the use of ECLS, taking into account data from the updated Extracorporeal Life Support Organization Registry, which provides important context for understanding the epidemiology and outcomes of these patients.
Keywords: Complications; ECLS; ECMO; ELSO registry; Infections; Nosocomial.
Conflict of interest statement
MS has received lectures fees from Getinge, Xenios and Dräger, outside the submitted work. DB reports fees to his university from ALung Technologies, personal fees from Baxter and anticipated fees from BREETHE, an unpaid association with Hemovent, outside the submitted work. GG received payment for lectures from Draeger Medical, Getinge, Fisher and Paykel, Pfizer, and received travel/accommodations/congress registration support from Getinge and Biotest, outside the submitted work.
Figures





References
-
- Abrams D, Garan AR, Abdelbary A, Bacchetta M, Bartlett RH, Beck J, Belohlavek J, Chen YS, Fan E, Ferguson ND, Fowles JA, Fraser J, Gong M, Hassan IF, Hodgson C, Hou X, Hryniewicz K, Ichiba S, Jakobleff WA, Lorusso R, MacLaren G, McGuinness S, Mueller T, Park PK, Peek G, Pellegrino V, Price S, Rosenzweig EB, Sakamoto T, Salazar L, Schmidt M, Slutsky AS, Spaulding C, Takayama H, Takeda K, Vuylsteke A, Combes A, Brodie D, International EN, The Extracorporeal Life Support O Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med. 2018;44:717–729. doi: 10.1007/s00134-018-5064-5. - DOI - PubMed
-
- Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, Neuville M, Zogheib E, Mira JP, Roze H, Pierrot M, Tobin A, Hodgson C, Chevret S, Brodie D, Combes A. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort. Am J Respir Crit Care Med. 2019;200:1002–1012. doi: 10.1164/rccm.201806-1094OC. - DOI - PubMed